arc grant results
Rare Disease Data Center vs Peer - Breakthroughs Exposed?
How Rare Disease Data Centers Transform Pharma R&D 35% of time-to-first-hit identification can be shaved off when a rare disease data center is woven into pharma R&D, as shown by Alexion’s 2026 AAN case study. The platform aggregates genomic phenotypes, electronic health records, and patient-reported